Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α

被引：0
|
作者：
Tromm, A
Greving, I
Hueppe, D
机构：
[1] BG Clinen BERGMANNSHEIL, Bochum, Germany
[2] Ruhr Univ Bochum, D-4630 Bochum, Germany
[3] Gastroemterp Fachpraxis, Herne, Germany
来源：
GASTROENTEROLOGY | 1999年 / 116卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G3621
引用
收藏
页码：A834 / A834
页数：1
相关论文
共 50 条
  • [31] Interferon-α in chronic hepatitis C
    Bruno, S
    Borzio, M
    Battezzati, PM
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) : 956 - 956
  • [32] Effects of Host and virus related factors on Interferon-α plus ribavirin and Pegylated-interferon plus ribavirin treatment outcomes in Chronic Hepatitis C patients
    Akram, Madiha
    Idrees, Muhammad
    Zafar, Shamail
    Hussain, Abrar
    Butt, Sadia
    Afzal, Samia
    Rehman, Irshad-ur
    Liaqat, Ali
    Saleem, Sana
    Ali, Muhammad
    Butt, Azeem
    VIROLOGY JOURNAL, 2011, 8
  • [33] Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin
    Overbeck, Kathrin
    Genne, Daniel
    Golay, Alain
    Negro, Francesco
    JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 295 - 298
  • [34] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [35] Combination therapy with interferon-α 2b and ribavirin for the treatment of relapse patients and non-responders with chronic HCV infection
    Kallinowski, B
    Liehr, H
    Moeller, B
    Stremmel, W
    Wechsler, JG
    Wiese, M
    Goeser, T
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (03): : 199 - +
  • [36] Randomized, controlled trial with interferon-α (IFN-α) combined with ribavirin with and without amantadinsulfat in primary IFN-α non-responders with chronic hepatitis C
    Teuber, G
    Berg, T
    Lafrenz, M
    Weidenbach, H
    Schoelmerich, J
    Wietzke-Braun, P
    Pausch, J
    Arnold, R
    Lock, G
    Udo, H
    Zeuzem, S
    GASTROENTEROLOGY, 2001, 120 (05) : A381 - A381
  • [37] Efficacy of ribavirin plus interferon-α in patients aged ≥60 years with chronic hepatitis C
    Honda, Takashi
    Katano, Yoshiaki
    Urano, Fumihiro
    Murayama, Mutsumi
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Nakano, Isao
    Yoshioka, Kentaro
    Toyoda, Hidenori
    Kumada, Takashi
    Goto, Hidemi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (07) : 989 - 995
  • [38] Sustained response to interferon-α or to interferon-α plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia
    Calleja, JL
    Albillos, A
    Moreno-Otero, R
    Rossi, I
    Cacho, G
    Domper, F
    Yebra, M
    Escartín, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (09) : 1179 - 1186
  • [39] Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy:: a meta-analysis of individual patient data
    Cammà, C
    Bruno, S
    Schepis, F
    Lo Iacono, O
    Andreone, P
    Gramenzi, AG
    Mangia, A
    Andriulli, A
    Puoti, M
    Spadaro, A
    Freni, M
    Di Marco, V
    Cino, L
    Saracco, G
    Chiesa, A
    Crosignani
    Caporaso, N
    Morisco, F
    Rumi, MG
    Craxì, A
    GUT, 2002, 51 (06) : 864 - 869
  • [40] Soluble interleukin 2 receptor plasma levels in non-responders with chronic hepatitis C treated with pegylated interferon-α 2b and ribavirin
    Henke, H
    Schmiegel, W
    Brechmann, T
    Voigt, E
    Griga, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (03) : 301 - 303
12345